Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
Seth J. Zost(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Luke Myers(Vanderbilt University Medical Center), David R. Martinez(University of North Carolina at Chapel Hill), Robert H. Carnahan(Vanderbilt University Medical Center), Rachel E. Sutton(Vanderbilt University Medical Center), Ralph S. Baric(University of North Carolina at Chapel Hill), Julie M. Fox(National Institutes of Health), Pavlo Gilchuk(AstraZeneca (Japan)), Larissa B. Thackray(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Ahmed O. Hassan(Washington University in St. Louis), Lisa E. Gralinski(University of North Carolina at Chapel Hill), Lauren E. Williamson(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Kuishu Ren(AstraZeneca (United States)), Elad Binshtein, Naveenchandra Suryadevara(Vanderbilt University), Rita E. Chen(Washington University in St. Louis), Andrew Trivette, Yueh–Ming Loo(Intego (Germany)), Joseph X. Reidy(Vanderbilt University Medical Center), Michael Diamond(Washington University in St. Louis), Elaine C. Chen(Vanderbilt University Medical Center), Taylor Jones(Vanderbilt University Medical Center), James J. Steinhardt(AstraZeneca (United States)), Nicole L. Kallewaard(AstraZeneca (United States)), Emma S. Winkler(Washington University in St. Louis), Samuel B. Day(Vanderbilt University Medical Center), Alexandra Schäfer(University of North Carolina at Chapel Hill), Natasha M. Kafai(Washington University in St. Louis)
Cited by 51
Related Papers
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k